| scholarly article | Q13442814 |
| P50 | author | Christina Maria Anna Pia Schuh | Q85222501 |
| P2093 | author name string | Fernando Ezquer | |
| Marcelo Ezquer | |||
| Valentina Castillo | |||
| Francisca Alcayaga-Miranda | |||
| Jimena Cuenca | |||
| Maroun Khoury | |||
| Alice Le-Gatt | |||
| Jose Belletti | |||
| Macarena Díaz | |||
| Mónica Kurte G | |||
| Paz L Gonzalez | |||
| P2860 | cites work | Clinical applications of mesenchymal stem cells | Q21198864 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy | Q26748517 | ||
| Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound | Q26753838 | ||
| Transition from inflammation to proliferation: a critical step during wound healing | Q28068273 | ||
| Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy | Q28069171 | ||
| Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells | Q28069791 | ||
| Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials | Q28071916 | ||
| Effects of matrix metalloproteinases on the fate of mesenchymal stem cells | Q28074717 | ||
| Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis | Q31133087 | ||
| PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements | Q31145457 | ||
| Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury | Q33624240 | ||
| The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy | Q33658078 | ||
| Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy | Q33708002 | ||
| Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators | Q33722100 | ||
| Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2. | Q33736914 | ||
| Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds | Q33869297 | ||
| Menstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues. | Q34253171 | ||
| Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential | Q34270505 | ||
| Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair | Q34422297 | ||
| IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis | Q34648364 | ||
| Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells | Q35505141 | ||
| Mesenchymal stromal cells for cutaneous wound healing in a rabbit model: pre-clinical study applicable in the pediatric surgical setting. | Q35685469 | ||
| Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation | Q35757437 | ||
| New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies | Q35924837 | ||
| The elusive nature and function of mesenchymal stem cells | Q35940531 | ||
| Desferrioxamine-driven upregulation of angiogenic factor expression by human bone marrow stromal cells | Q46567739 | ||
| Comparative restoration of acute liver failure by menstrual blood stem cells compared with bone marrow stem cells in mice model. | Q47436002 | ||
| Interleukin 6 indirectly induces keratinocyte migration | Q47758353 | ||
| Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds | Q50472867 | ||
| Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis | Q50674319 | ||
| Platelet-rich plasma (PRP) and adipose-derived mesenchymal stem cells: stimulatory effects on proliferation and migration of fibroblasts and keratinocytes in vitro | Q51256663 | ||
| Quantitative and reproducible murine model of excisional wound healing. | Q51645013 | ||
| The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study. | Q53362729 | ||
| Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation | Q59734188 | ||
| Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
| The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases | Q62083499 | ||
| Interleukin-6 (IL-6) modulates migration and matrix metalloproteinase function in dermal fibroblasts from IL-6KO mice | Q80176176 | ||
| Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays | Q83142880 | ||
| Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells | Q36067842 | ||
| Therapeutic angiogenesis induced by human umbilical cord tissue-derived mesenchymal stromal cells in a murine model of hindlimb ischemia | Q36146690 | ||
| Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis | Q36172222 | ||
| Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta | Q36352371 | ||
| Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice | Q36380638 | ||
| Endometrial regenerative cells: a novel stem cell population | Q36402092 | ||
| Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic | Q36690614 | ||
| Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation | Q36968300 | ||
| The Potential of Menstrual Blood-Derived Stem Cells in Differentiation to Epidermal Lineage: A Preliminary Report | Q36995967 | ||
| CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex | Q37112245 | ||
| Feasibility investigation of allogeneic endometrial regenerative cells | Q37114094 | ||
| Wound repair and regeneration: mechanisms, signaling, and translation | Q37152090 | ||
| Mesenchymal stromal cell characteristics vary depending on their origin | Q37190239 | ||
| Enhanced healing of diabetic wounds by subcutaneous administration of human umbilical cord derived stem cells and their conditioned media. | Q37194835 | ||
| Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies | Q37727501 | ||
| Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. | Q37875244 | ||
| Mesenchymal stromal cells: sensors and switchers of inflammation | Q38149359 | ||
| Activity of mesenchymal stem cells in therapies for chronic skin wound healing. | Q38169955 | ||
| Mesenchymal stem cells for chronic wounds therapy. | Q38197918 | ||
| Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors | Q38198130 | ||
| Therapeutic uses of anti-interleukin-6 receptor antibody | Q38241714 | ||
| Clinical Trials With Mesenchymal Stem Cells: An Update. | Q38596084 | ||
| In vitro differentiation of menstrual blood stem cells into keratinocytes: A potential approach for management of wound healing | Q38674979 | ||
| Role of heparin and non heparin binding serpins in coagulation and angiogenesis: A complex interplay | Q38884470 | ||
| Stromal vascular fraction shows robust wound healing through high chemotactic and epithelialization property | Q38956541 | ||
| Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms | Q39204642 | ||
| Effect of menstrual blood-derived stromal stem cells on proliferative capacity of peripheral blood mononuclear cells in allogeneic mixed lymphocyte reaction | Q39638248 | ||
| A full skin defect model to evaluate vascularization of biomaterials in vivo | Q40043279 | ||
| Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections. | Q40075675 | ||
| Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins. | Q40470487 | ||
| Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. | Q42176451 | ||
| Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation | Q44748483 | ||
| The mouse excisional wound splinting model, including applications for stem cell transplantation | Q44804631 | ||
| IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. | Q45002998 | ||
| P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts. | Q45977949 | ||
| Chronic wound care | Q46430417 | ||
| Umbilical cord-derived mesenchymal stromal cell-conditioned medium exerts in vitro antiaging effects in human fibroblasts | Q46433352 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | menstruation | Q12171 |
| P304 | page(s) | 464 | |
| P577 | publication date | 2018-05-14 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration | |
| P478 | volume | 9 |
| Q92173428 | Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases |
| Q104111207 | Menstrual blood-derived stromal cells modulate functional properties of mouse and human macrophages |
| Q60922074 | The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine |
Search more.